Cortical phase changes in Alzheimer's disease at 7T MRI: A novel imaging marker

Abstract Background Postmortem studies have indicated the potential of high-field magnetic resonance imaging (MRI) to visualize amyloid depositions in the cerebral cortex. The aim of this study is to test this hypothesis in patients with Alzheimer's disease (AD). Methods T2*-weighted MRI was pe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Alzheimer's & dementia 2014-01, Vol.10 (1), p.e19-e26
Hauptverfasser: van Rooden, Sanneke, Versluis, Maarten J, Liem, Michael K, Milles, Julien, Maier, Andrea B, Oleksik, Ania M, Webb, Andrew G, van Buchem, Mark A, van der Grond, Jeroen
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e26
container_issue 1
container_start_page e19
container_title Alzheimer's & dementia
container_volume 10
creator van Rooden, Sanneke
Versluis, Maarten J
Liem, Michael K
Milles, Julien
Maier, Andrea B
Oleksik, Ania M
Webb, Andrew G
van Buchem, Mark A
van der Grond, Jeroen
description Abstract Background Postmortem studies have indicated the potential of high-field magnetic resonance imaging (MRI) to visualize amyloid depositions in the cerebral cortex. The aim of this study is to test this hypothesis in patients with Alzheimer's disease (AD). Methods T2*-weighted MRI was performed in 16 AD patients and 15 control subjects. All magnetic resonance images were scored qualitatively by visual assessment, and quantitatively by measuring phase shifts in the cortical gray matter and hippocampus. Statistical analysis was performed to assess differences between groups. Results Patients with AD demonstrated an increased phase shift in the cortex in the temporoparietal, frontal, and parietal regions ( P < .005), and this was associated with individual Mini-Mental State Examination scores ( r  = −0.54, P < .05). Conclusion Increased cortical phase shift in AD patients demonstrated on 7-tesla T2*-weighted MRI is a potential new biomarker for AD, which may reflect amyloid pathology in the early stages.
doi_str_mv 10.1016/j.jalz.2013.02.002
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1558990599</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1552526013000721</els_id><sourcerecordid>1490745509</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5932-cf7bbe96b9694e849b3a78d3f4ca486bfa1daa1367d52d7f606fac101ff34c4b3</originalsourceid><addsrcrecordid>eNqNUk1vEzEUXCEQLYU_wAH5Bpcszx-7XiNUaRVRaBVUCcqFi-X1vk283Y9gJ63SX49XCT1wgFxsy54Zv_dmkuQ1hZQCzd-3aWu6h5QB5SmwFIA9SU5plrFZxqR6-njO4SR5EUILIKCg2fPkhHFJWcSfJtfz0W-cNR1Zr0xAYldmWGIgbiBl97BC16N_G0jtAk7PZkPkDfn67fIDKckw3mFHXG-WbliS3vhb9C-TZ43pAr467GfJj4tPN_Mvs8X158t5uZjZTHE2s42sKlR5pXIlsBCq4kYWNW-ENaLIq8bQ2hjKc1lnrJZNDnljbOy6abiwouJnybu97tqPv7YYNrp3wWLXmQHHbdCx9UIpyJQ6AspFQWUuiiOgAFIWBYP_Q4UCKbIMpgLYHmr9GILHRq99nJrfaQp6clK3enJST05qYDo6E0lvDvrbqsf6kfLHuggo94B71-HuCEldLn5eXcVluoODxse9Bkar7hx6HazDwWLtPNqNrkf37xrP_6Lbzg1Tmm5xh6Edt36IIdBUh0jQ36c8TnGM38c5Msp_A_oZ1Kw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1490745509</pqid></control><display><type>article</type><title>Cortical phase changes in Alzheimer's disease at 7T MRI: A novel imaging marker</title><source>MEDLINE</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>Wiley Online Library All Journals</source><creator>van Rooden, Sanneke ; Versluis, Maarten J ; Liem, Michael K ; Milles, Julien ; Maier, Andrea B ; Oleksik, Ania M ; Webb, Andrew G ; van Buchem, Mark A ; van der Grond, Jeroen</creator><creatorcontrib>van Rooden, Sanneke ; Versluis, Maarten J ; Liem, Michael K ; Milles, Julien ; Maier, Andrea B ; Oleksik, Ania M ; Webb, Andrew G ; van Buchem, Mark A ; van der Grond, Jeroen</creatorcontrib><description>Abstract Background Postmortem studies have indicated the potential of high-field magnetic resonance imaging (MRI) to visualize amyloid depositions in the cerebral cortex. The aim of this study is to test this hypothesis in patients with Alzheimer's disease (AD). Methods T2*-weighted MRI was performed in 16 AD patients and 15 control subjects. All magnetic resonance images were scored qualitatively by visual assessment, and quantitatively by measuring phase shifts in the cortical gray matter and hippocampus. Statistical analysis was performed to assess differences between groups. Results Patients with AD demonstrated an increased phase shift in the cortex in the temporoparietal, frontal, and parietal regions ( P &lt; .005), and this was associated with individual Mini-Mental State Examination scores ( r  = −0.54, P &lt; .05). Conclusion Increased cortical phase shift in AD patients demonstrated on 7-tesla T2*-weighted MRI is a potential new biomarker for AD, which may reflect amyloid pathology in the early stages.</description><identifier>ISSN: 1552-5260</identifier><identifier>EISSN: 1552-5279</identifier><identifier>DOI: 10.1016/j.jalz.2013.02.002</identifier><identifier>PMID: 23712002</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>AD pathology ; Aged ; Aged, 80 and over ; Alzheimer Disease - pathology ; Alzheimer's disease ; Biological markers ; Biomarker ; Brain imaging ; Cerebral Cortex - pathology ; Entorhinal cortex ; Female ; Hippocampus ; Human 7T MRI ; Humans ; Image Processing, Computer-Assisted ; Magnetic Resonance Imaging ; Male ; Neurology ; Pathology ; Phase changes ; Statistics, Nonparametric</subject><ispartof>Alzheimer's &amp; dementia, 2014-01, Vol.10 (1), p.e19-e26</ispartof><rights>The Alzheimer's Association</rights><rights>2014 The Alzheimer's Association</rights><rights>Copyright © 2014 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5932-cf7bbe96b9694e849b3a78d3f4ca486bfa1daa1367d52d7f606fac101ff34c4b3</citedby><cites>FETCH-LOGICAL-c5932-cf7bbe96b9694e849b3a78d3f4ca486bfa1daa1367d52d7f606fac101ff34c4b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1016%2Fj.jalz.2013.02.002$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1016%2Fj.jalz.2013.02.002$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,30999,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23712002$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>van Rooden, Sanneke</creatorcontrib><creatorcontrib>Versluis, Maarten J</creatorcontrib><creatorcontrib>Liem, Michael K</creatorcontrib><creatorcontrib>Milles, Julien</creatorcontrib><creatorcontrib>Maier, Andrea B</creatorcontrib><creatorcontrib>Oleksik, Ania M</creatorcontrib><creatorcontrib>Webb, Andrew G</creatorcontrib><creatorcontrib>van Buchem, Mark A</creatorcontrib><creatorcontrib>van der Grond, Jeroen</creatorcontrib><title>Cortical phase changes in Alzheimer's disease at 7T MRI: A novel imaging marker</title><title>Alzheimer's &amp; dementia</title><addtitle>Alzheimers Dement</addtitle><description>Abstract Background Postmortem studies have indicated the potential of high-field magnetic resonance imaging (MRI) to visualize amyloid depositions in the cerebral cortex. The aim of this study is to test this hypothesis in patients with Alzheimer's disease (AD). Methods T2*-weighted MRI was performed in 16 AD patients and 15 control subjects. All magnetic resonance images were scored qualitatively by visual assessment, and quantitatively by measuring phase shifts in the cortical gray matter and hippocampus. Statistical analysis was performed to assess differences between groups. Results Patients with AD demonstrated an increased phase shift in the cortex in the temporoparietal, frontal, and parietal regions ( P &lt; .005), and this was associated with individual Mini-Mental State Examination scores ( r  = −0.54, P &lt; .05). Conclusion Increased cortical phase shift in AD patients demonstrated on 7-tesla T2*-weighted MRI is a potential new biomarker for AD, which may reflect amyloid pathology in the early stages.</description><subject>AD pathology</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alzheimer Disease - pathology</subject><subject>Alzheimer's disease</subject><subject>Biological markers</subject><subject>Biomarker</subject><subject>Brain imaging</subject><subject>Cerebral Cortex - pathology</subject><subject>Entorhinal cortex</subject><subject>Female</subject><subject>Hippocampus</subject><subject>Human 7T MRI</subject><subject>Humans</subject><subject>Image Processing, Computer-Assisted</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Neurology</subject><subject>Pathology</subject><subject>Phase changes</subject><subject>Statistics, Nonparametric</subject><issn>1552-5260</issn><issn>1552-5279</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNqNUk1vEzEUXCEQLYU_wAH5Bpcszx-7XiNUaRVRaBVUCcqFi-X1vk283Y9gJ63SX49XCT1wgFxsy54Zv_dmkuQ1hZQCzd-3aWu6h5QB5SmwFIA9SU5plrFZxqR6-njO4SR5EUILIKCg2fPkhHFJWcSfJtfz0W-cNR1Zr0xAYldmWGIgbiBl97BC16N_G0jtAk7PZkPkDfn67fIDKckw3mFHXG-WbliS3vhb9C-TZ43pAr467GfJj4tPN_Mvs8X158t5uZjZTHE2s42sKlR5pXIlsBCq4kYWNW-ENaLIq8bQ2hjKc1lnrJZNDnljbOy6abiwouJnybu97tqPv7YYNrp3wWLXmQHHbdCx9UIpyJQ6AspFQWUuiiOgAFIWBYP_Q4UCKbIMpgLYHmr9GILHRq99nJrfaQp6clK3enJST05qYDo6E0lvDvrbqsf6kfLHuggo94B71-HuCEldLn5eXcVluoODxse9Bkar7hx6HazDwWLtPNqNrkf37xrP_6Lbzg1Tmm5xh6Edt36IIdBUh0jQ36c8TnGM38c5Msp_A_oZ1Kw</recordid><startdate>201401</startdate><enddate>201401</enddate><creator>van Rooden, Sanneke</creator><creator>Versluis, Maarten J</creator><creator>Liem, Michael K</creator><creator>Milles, Julien</creator><creator>Maier, Andrea B</creator><creator>Oleksik, Ania M</creator><creator>Webb, Andrew G</creator><creator>van Buchem, Mark A</creator><creator>van der Grond, Jeroen</creator><general>Elsevier Inc</general><general>ALZHEIMER'S &amp; DEMENTIA</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7TK</scope><scope>7QJ</scope></search><sort><creationdate>201401</creationdate><title>Cortical phase changes in Alzheimer's disease at 7T MRI: A novel imaging marker</title><author>van Rooden, Sanneke ; Versluis, Maarten J ; Liem, Michael K ; Milles, Julien ; Maier, Andrea B ; Oleksik, Ania M ; Webb, Andrew G ; van Buchem, Mark A ; van der Grond, Jeroen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5932-cf7bbe96b9694e849b3a78d3f4ca486bfa1daa1367d52d7f606fac101ff34c4b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>AD pathology</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alzheimer Disease - pathology</topic><topic>Alzheimer's disease</topic><topic>Biological markers</topic><topic>Biomarker</topic><topic>Brain imaging</topic><topic>Cerebral Cortex - pathology</topic><topic>Entorhinal cortex</topic><topic>Female</topic><topic>Hippocampus</topic><topic>Human 7T MRI</topic><topic>Humans</topic><topic>Image Processing, Computer-Assisted</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Neurology</topic><topic>Pathology</topic><topic>Phase changes</topic><topic>Statistics, Nonparametric</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>van Rooden, Sanneke</creatorcontrib><creatorcontrib>Versluis, Maarten J</creatorcontrib><creatorcontrib>Liem, Michael K</creatorcontrib><creatorcontrib>Milles, Julien</creatorcontrib><creatorcontrib>Maier, Andrea B</creatorcontrib><creatorcontrib>Oleksik, Ania M</creatorcontrib><creatorcontrib>Webb, Andrew G</creatorcontrib><creatorcontrib>van Buchem, Mark A</creatorcontrib><creatorcontrib>van der Grond, Jeroen</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Neurosciences Abstracts</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><jtitle>Alzheimer's &amp; dementia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>van Rooden, Sanneke</au><au>Versluis, Maarten J</au><au>Liem, Michael K</au><au>Milles, Julien</au><au>Maier, Andrea B</au><au>Oleksik, Ania M</au><au>Webb, Andrew G</au><au>van Buchem, Mark A</au><au>van der Grond, Jeroen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cortical phase changes in Alzheimer's disease at 7T MRI: A novel imaging marker</atitle><jtitle>Alzheimer's &amp; dementia</jtitle><addtitle>Alzheimers Dement</addtitle><date>2014-01</date><risdate>2014</risdate><volume>10</volume><issue>1</issue><spage>e19</spage><epage>e26</epage><pages>e19-e26</pages><issn>1552-5260</issn><eissn>1552-5279</eissn><abstract>Abstract Background Postmortem studies have indicated the potential of high-field magnetic resonance imaging (MRI) to visualize amyloid depositions in the cerebral cortex. The aim of this study is to test this hypothesis in patients with Alzheimer's disease (AD). Methods T2*-weighted MRI was performed in 16 AD patients and 15 control subjects. All magnetic resonance images were scored qualitatively by visual assessment, and quantitatively by measuring phase shifts in the cortical gray matter and hippocampus. Statistical analysis was performed to assess differences between groups. Results Patients with AD demonstrated an increased phase shift in the cortex in the temporoparietal, frontal, and parietal regions ( P &lt; .005), and this was associated with individual Mini-Mental State Examination scores ( r  = −0.54, P &lt; .05). Conclusion Increased cortical phase shift in AD patients demonstrated on 7-tesla T2*-weighted MRI is a potential new biomarker for AD, which may reflect amyloid pathology in the early stages.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>23712002</pmid><doi>10.1016/j.jalz.2013.02.002</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1552-5260
ispartof Alzheimer's & dementia, 2014-01, Vol.10 (1), p.e19-e26
issn 1552-5260
1552-5279
language eng
recordid cdi_proquest_miscellaneous_1558990599
source MEDLINE; Applied Social Sciences Index & Abstracts (ASSIA); Wiley Online Library All Journals
subjects AD pathology
Aged
Aged, 80 and over
Alzheimer Disease - pathology
Alzheimer's disease
Biological markers
Biomarker
Brain imaging
Cerebral Cortex - pathology
Entorhinal cortex
Female
Hippocampus
Human 7T MRI
Humans
Image Processing, Computer-Assisted
Magnetic Resonance Imaging
Male
Neurology
Pathology
Phase changes
Statistics, Nonparametric
title Cortical phase changes in Alzheimer's disease at 7T MRI: A novel imaging marker
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T12%3A42%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cortical%20phase%20changes%20in%20Alzheimer's%20disease%20at%207T%20MRI:%20A%20novel%20imaging%20marker&rft.jtitle=Alzheimer's%20&%20dementia&rft.au=van%20Rooden,%20Sanneke&rft.date=2014-01&rft.volume=10&rft.issue=1&rft.spage=e19&rft.epage=e26&rft.pages=e19-e26&rft.issn=1552-5260&rft.eissn=1552-5279&rft_id=info:doi/10.1016/j.jalz.2013.02.002&rft_dat=%3Cproquest_cross%3E1490745509%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1490745509&rft_id=info:pmid/23712002&rft_els_id=1_s2_0_S1552526013000721&rfr_iscdi=true